Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference

BOSTON, Nov. 26, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced that Joseph J. Ferra, President and Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Piper Sandler 36^th Annual Healthcare Conference on Tuesday, December 3, 2024, at 8:30 a.m. ET.